Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Clinical and Molecular Characteristics of DDX41 -Mutated Patients in a Large Cohort of Sporadic MDS/AML

Marie Sebert, MD, Marie Passet, PharmD, Anna Raimbault, PhD, Samuel Quentin, Nadia Vasquez, Ramy Rahmé, Emmanuel Raffoux, Flore Sicre De Fontbrune, MD PhD, Regis Peffault De Latour, Raphael Itzykson, MD PhD, Pierre Fenaux, MD PhD, Jean Soulier, MDPhD, Lionel Ades, MD PhD, Emmanuelle Clappier, PhD PharmD

Blood (2018) 132 (Supplement 1): 797.

https://doi.org/10.1182/blood-2018-99-110668

Published: 2018

Journal Articles

IKZF1 deletions in Pediatric Acute Myeloid Leukemia

Jasmijn de Rooij, MD, Eva Beuling, PhD, C. Michel Zwaan, Askar Obulkasim, André Baruchel, MD, Jan Trka, MD PhD, Dirk Reinhardt, MD PhD, Edwin Sonneveld, PhD, Brenda Gibson, Martin Zimmermann, Rob Pieters, MD PhD, Marry van den Heuvel-Eibrink, MD PhD, Maarten Fornerod, PhD

Blood (2014) 124 (21): 2346.

https://doi.org/10.1182/blood.V124.21.2346.2346

Published: 2014

Journal Articles

Do Early Events Excluding Patients with Acute Promyelocytic Leukemia (APL) From Trial Enrollment Modify Treatment Result Evaluation? Real-Life Management of 100 Patients Referred to the University Hospital Saint-Louis Between 2000 and 2010.

Jean-Baptiste Micol, Emmanuel Raffoux, MD, Nicolas Boissel, MD, PhD, Etienne Lengliné, MD, Emmanuel Canet, Thierry Leblanc, Marie-Thérèse Daniel, Adrienne de Labarthe, Odile Maarek, Bruno Cassinat, Christine Chomienne, MD, PhD, Lionel Adès, André Baruchel, Laurent Degos, Elie Azoulay, MD, PhD, Hervé Dombret

Blood (2010) 116 (21): 1083.

https://doi.org/10.1182/blood.V116.21.1083.1083

Published: 2010

Journal Articles

Comorbidity Indexes and Allogeneic Stem Cell Transplantation (SCT).

Alienor Xhaard, MD, Raphael Porcher, PhD, Jason Chien, MD, PhD, Regis Peffault de Latour, MD, PhD, Marie Robin, MD, Patricia Ribaud, MD, Paul J. Martin, MD, PhD, Gérard Socié, MD, PhD

Blood (2007) 110 (11): 1985.

https://doi.org/10.1182/blood.V110.11.1985.1985

Published: 2007

Journal Articles

Mycophenolate Mofetil (MMF) with or without Tracolimus (FK506) as a Second Line Treatment for Steroid-Resistant Acute Graft-Versus-Host Disease. The Experience of Saint Louis Hospital.

Gustavo Fisher, MD, Vanderson Rocha, MD, PhD, Moema dos Santos, MD, Agnes Devergie, MD, Marie Robin, MD, Regis P. de Latour, MD, Patricia Ribaud, MD, Christele Ferry, MD, Eliane Gluckman, MD, FRCP, Gerard Socie, MD, PhD

Blood (2006) 108 (11): 2892.

https://doi.org/10.1182/blood.V108.11.2892.2892

Published: 2006

Journal Articles

Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants

Philip S. Rosenberg, Gerard Socié, Blanche P. Alter, Eliane Gluckman

Blood (2005) 105 (1): 67–73.

https://doi.org/10.1182/blood-2004-04-1652

Published: 2005

NARROW

Clinical and Molecular Characteristics of DDX41 -Mutated Patients in a Large Cohort of Sporadic MDS/AML

IKZF1 deletions in Pediatric Acute Myeloid Leukemia

Do Early Events Excluding Patients with Acute Promyelocytic Leukemia (APL) From Trial Enrollment Modify Treatment Result Evaluation? Real-Life Management of 100 Patients Referred to the University Hospital Saint-Louis Between 2000 and 2010.

Comorbidity Indexes and Allogeneic Stem Cell Transplantation (SCT).

Mycophenolate Mofetil (MMF) with or without Tracolimus (FK506) as a Second Line Treatment for Steroid-Resistant Acute Graft-Versus-Host Disease. The Experience of Saint Louis Hospital.

Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants

Email alerts

ASH Publications

American Society of Hematology

Clinical and Molecular Characteristics of DDX41 -Mutated Patients in a Large Cohort of Sporadic MDS/AML

IKZF1 deletions in Pediatric Acute Myeloid Leukemia

Do Early Events Excluding Patients with Acute Promyelocytic Leukemia (APL) From Trial Enrollment Modify Treatment Result Evaluation? Real-Life Management of 100 Patients Referred to the University Hospital Saint-Louis Between 2000 and 2010.

Comorbidity Indexes and Allogeneic Stem Cell Transplantation (SCT).

Mycophenolate Mofetil (MMF) with or without Tracolimus (FK506) as a Second Line Treatment for Steroid-Resistant Acute Graft-Versus-Host Disease. The Experience of Saint Louis Hospital.

Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only